[go: up one dir, main page]

AU472127B2 - Heterocyclic compounds - Google Patents

Heterocyclic compounds

Info

Publication number
AU472127B2
AU472127B2 AU48191/72A AU4819172A AU472127B2 AU 472127 B2 AU472127 B2 AU 472127B2 AU 48191/72 A AU48191/72 A AU 48191/72A AU 4819172 A AU4819172 A AU 4819172A AU 472127 B2 AU472127 B2 AU 472127B2
Authority
AU
Australia
Prior art keywords
heterocyclic compounds
heterocyclic
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU48191/72A
Other versions
AU4819172A (en
Inventor
DAVID HARTLEY LAWRENCE HENRY CHARLES LUNIS and ALEXANDER WILLIAM OXFORD SUSAN CONSTANCE GARSIDE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allen and Hanburys Ltd
Original Assignee
Allen and Hanburys Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allen and Hanburys Ltd filed Critical Allen and Hanburys Ltd
Publication of AU4819172A publication Critical patent/AU4819172A/en
Application granted granted Critical
Publication of AU472127B2 publication Critical patent/AU472127B2/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • C07D253/0651,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/071,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075Two hetero atoms, in positions 3 and 5
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU48191/72A 1971-11-19 1972-10-26 Heterocyclic compounds Expired AU472127B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB5375071A GB1400999A (en) 1971-11-19 1971-11-19 Imidazo-triazine compounds and their use in therapeutic compositions
GBGB53750/71 1971-11-19

Publications (2)

Publication Number Publication Date
AU4819172A AU4819172A (en) 1974-05-16
AU472127B2 true AU472127B2 (en) 1976-05-20

Family

ID=10468856

Family Applications (1)

Application Number Title Priority Date Filing Date
AU48191/72A Expired AU472127B2 (en) 1971-11-19 1972-10-26 Heterocyclic compounds

Country Status (18)

Country Link
US (1) US3840537A (en)
JP (1) JPS563873B2 (en)
AT (1) AT321923B (en)
AU (1) AU472127B2 (en)
BE (1) BE791025A (en)
CA (1) CA990292A (en)
CH (1) CH594671A5 (en)
DE (1) DE2255172A1 (en)
DK (1) DK138691B (en)
ES (1) ES408736A1 (en)
FR (1) FR2160407B1 (en)
GB (1) GB1400999A (en)
IE (1) IE37046B1 (en)
IL (1) IL40686A (en)
NL (1) NL7215646A (en)
PH (1) PH9669A (en)
SE (1) SE402915B (en)
ZA (1) ZA727532B (en)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1457873A (en) * 1973-01-04 1976-12-08 Allen & Hanburys Ltd Imidazotriazines
DE2314488C3 (en) * 1973-03-23 1979-01-04 C.H. Boehringer Sohn, 6507 Ingelheim 8- (2,6-Dichlorophenyl) -7- (4-chlorophenyl) -5-oxo-233,8-tetrahydro-imidazo [1,2-a] -s-triazine, process for its preparation and medicament containing it
DE2335193A1 (en) * 1973-07-11 1975-01-30 Hoechst Ag BIS-TRIAZINOBENZIMIDAZOLE AND THEIR PRODUCTION
US4115572A (en) * 1977-02-03 1978-09-19 American Cyanamid Company Imidazo-[1,5-d]-as-triazin-1(2H)-ones and method of ameliorating asthma
USRE30511E (en) * 1977-02-03 1981-02-10 American Cyanamid Company Imidazo[1,5-d]-as-triazine-4(3H)-ones and thiones
US4107307A (en) * 1977-02-03 1978-08-15 American Cyanamid Company Imidazo [1,5-d]-as-triazine-4(3H)-ones and thiones
DK109578A (en) * 1977-03-25 1978-09-26 Allen & Hanburys Ltd PROCEDURE FOR MAKING HETEROCYCLIC COMPOUNDS
US4107308A (en) * 1977-10-18 1978-08-15 American Cyanamid Company Imidazo[1,5-d]-as-triazines
US4308384A (en) * 1978-09-18 1981-12-29 Glaxo Group Limited Production of triazinones
HU187474B (en) * 1981-11-18 1986-01-28 Gyogyszerkutato Intezet,Hu Process for producing new spiro-pyrazole-square bracket-1,5-d-square bracket closed-square bracket-1,2,4-square bracket closed-triazine derivatives
US4395547A (en) * 1982-02-10 1983-07-26 American Cyanamid Co. Process for preparing 1-substituted-6-n-propyl-8-methylimidazo[1,5-d]-as-triazin-4(3H)-ones
AU622330B2 (en) * 1989-06-23 1992-04-02 Takeda Chemical Industries Ltd. Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
US6624181B1 (en) * 1997-02-28 2003-09-23 Altana Pharma Ag Synergistic combination
IL135462A0 (en) 1997-11-12 2001-05-20 Bayer Ag 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
DE19827640A1 (en) * 1998-06-20 1999-12-23 Bayer Ag New imidazotriazine derivatives useful as smooth muscle relaxants for treating e.g. cardiovascular disorders, cerebrovascular disorders, or erectile dysfunction
JP2002523452A (en) 1998-08-26 2002-07-30 スミスクライン・ビーチャム・コーポレイション How to treat lung disease
AU777012B2 (en) * 1999-08-21 2004-09-30 Takeda Gmbh Synergistic combination of PDE inhibitors and beta 2 adrenoceptor agonist
BR0209541A (en) * 2001-05-09 2004-04-20 Bayer Healthcare Ag Use of 2-phenyl-substituted imidazotriazinones
GB0113343D0 (en) * 2001-06-01 2001-07-25 Bayer Ag Novel Heterocycles 2
GB0113344D0 (en) * 2001-06-01 2001-07-25 Bayer Ag Novel heterocycles 3
DE10135815A1 (en) 2001-07-23 2003-02-06 Bayer Ag Use of imidazo-triazinone derivative phosphodiesterase 5 inhibitors e.g. for treatment of cardiac insufficiency, psoriasis, diabetes, cancer, glaucoma, bladder disease, Parkinson's disease or pain
DE10232113A1 (en) * 2002-07-16 2004-01-29 Bayer Ag Medicinal products containing vardenafil hydrochloride trihydrate
JP2006522127A (en) * 2003-04-01 2006-09-28 スミスクライン ビーチャム コーポレーション Imidazotriazine compounds
EP2308879A1 (en) 2004-04-02 2011-04-13 OSI Pharmaceuticals, Inc. 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
DE102005001989A1 (en) * 2005-01-15 2006-07-20 Bayer Healthcare Ag Intravenous formulations of PDE inhibitors
DE102005009241A1 (en) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Dosage forms with controlled bioavailability
DE102005009240A1 (en) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Dosage forms with improved pharmacokinetic properties
RU2435588C2 (en) * 2005-09-29 2011-12-10 Байер Шеринг Фарма Акциенгезельшафт Pde inhibitors and their combinations for treatment of urologic disorders
RS51843B (en) 2005-11-17 2012-02-29 Osi Pharmaceuticals Llc. CONDENSED BICYCLIC m TOR INHIBITORS
JP2010532319A (en) * 2007-06-13 2010-10-07 バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト PDE inhibitors for the treatment of hearing impairment
JP2012524119A (en) 2009-04-20 2012-10-11 オーエスアイ・ファーマシューティカルズ,エルエルシー Preparation of C-pyrazine-methylamine
CN103374002B (en) * 2012-04-19 2015-07-15 山东轩竹医药科技有限公司 Phosphodiesterase-5 inhibitor
TW201639851A (en) * 2015-03-16 2016-11-16 大日本住友製藥股份有限公司 Bicyclic imidazolo derivative
WO2017000276A1 (en) * 2015-07-01 2017-01-05 Merck Sharp & Dohme Corp. Bicyclic heterocyclic compounds as pde2 inhibitors
WO2017204316A1 (en) * 2016-05-27 2017-11-30 塩野義製薬株式会社 5-oxo-1,2,4-triazine derivative, and pharmaceutical composition thereof

Also Published As

Publication number Publication date
DK138691B (en) 1978-10-16
IE37046L (en) 1973-05-19
CA990292A (en) 1976-06-01
ZA727532B (en) 1973-07-25
GB1400999A (en) 1975-07-16
IL40686A0 (en) 1972-12-29
JPS563873B2 (en) 1981-01-27
AU4819172A (en) 1974-05-16
PH9669A (en) 1976-02-10
US3840537A (en) 1974-10-08
IL40686A (en) 1975-12-31
ES408736A1 (en) 1976-03-01
IE37046B1 (en) 1977-04-27
DK138691C (en) 1979-03-26
DE2255172A1 (en) 1973-05-24
CH594671A5 (en) 1978-01-13
BE791025A (en) 1973-05-07
SE402915B (en) 1978-07-24
FR2160407A1 (en) 1973-06-29
NL7215646A (en) 1973-05-22
FR2160407B1 (en) 1975-10-17
JPS4857993A (en) 1973-08-14
AT321923B (en) 1975-04-25

Similar Documents

Publication Publication Date Title
AU472127B2 (en) Heterocyclic compounds
CA1017336A (en) Divinyl-diphenyl compounds
AU459132B2 (en) Etrachlorophthalide compounds
AU466025B2 (en) Aminohalopyridyloxy compounds
CA1026346A (en) Triazolyphosphorus compounds
CA1006163A (en) Arylaminopyridine compounds
AU466453B2 (en) Triaszolothienodiazepine compounds
AU468514B2 (en) Heterocyclic compounds
CA1019871A (en) Arc- and track - resistant polyepoxide - polysiloxane compounds
AU4356572A (en) New heterocyclic compounds
CA863349A (en) Heterocyclic compounds
CA993445A (en) Heterocyclic triglycidyl compounds
CA1001641A (en) Polyhalobenzylic disulfooxonium compounds
CA924724A (en) Heterocyclic compounds
CA879695A (en) Heterocyclic compounds
AU460576B2 (en) Heterocyclic compounds
AU3920372A (en) Heterocyclic compounds
CA878540A (en) Heterocyclic organoborines
CA875568A (en) Heterocyclic derivatives
CA880906A (en) Aryl-substituted heterocyclic compounds
AU461803B2 (en) Substituted guamidine compounds
CA1015751A (en) Substituted pyridopyrimidinone compounds
CA877313A (en) Heterocyclic spiro compounds
AU445230B2 (en) Halogenated heterocyclic compounds
AU477713B2 (en) Metallised heterocyclic compounds